Analysts have upgraded their buying recommendation for shares of accounting
software giant Sage from “hold” to “buy” .
Citigroup analysts said Sage stock was undervalued and speculated whether the
company would sell its US arm.
The company put on 6.8 to 257p on the back of the news, a rise of 2.4%.
“Sage has been de-rated as it is widely viewed as ex-growth. We disagree with
this assessment,” Citigroup analysts said.
“We think inflated US healthcare software valuations offer an opportunity for
disposal.”
Further reading:
Sage
warns of VAT change complications